Leadership vacancies are often framed as periods of risk. But they can also be moments of tremendous opportunity.

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity Corporation (NYSE: NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company ...

Leadership transitions are inevitable in accounting firms, but confidence during transition is not. That was the central theme of a recent virtual campfire I hosted for the Association for Accounting ...

Building on a record-setting 2025 that featured continued growth and momentum, Women in Motorsports North America (WIMNA) has announced a significant leadership transition and the appointment of ...

In this episode we are joined by Kathryn Sugerman and Nordia Edwards, consultants at leadership advisory firm Spencer Stuart, to discuss movement at the CEO level, the benefits of multi-year ...

Use this healthcare executive checklist to navigate leadership transitions with priorities for stabilization, structure, and momentum in the first 90 days.

Command is a pivotal experience and a career-defining opportunity. The scope of responsibility and depth of impact can be immense. For many, command introduces a level of complexity, ambiguity, and ...

Clinical progress, pipeline expansion, and operational momentum underpin leadership continuity as the Company advances into 2026 and beyond SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo ...

Building on a leadership transition shared in December, MyMichigan Health has announced additional changes to its executive roles and Medical Center leadership. Effective March 1, Hunter Nostrant will ...

Earnings Call Insights: Sixth Street Specialty Lending, Inc. (TSLX) Q3 2025 Simmonds stated, "Based on our performance this year through Q3, we expect adjusted NII per share for the full year to be at ...

SEATTLE, WA / ACCESS Newswire / February 3, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company developing novel immune-oncology therapeutics based on its proprietary ...